Search Results | American Association for Cancer Research

1-20 of 736

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Molecular Pathways and Mechanisms of LAG-3 in Cancer Therapy

Lawrence P. Andrews, Anthony R. Cillo, Lilit Karapetyan, John M. Kirkwood, Creg J. Workman, Dario A.A. Vignali

Clin Cancer Res OF1–OF10.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-2390

Published: 26 May 2022

View article

Journal Articles

Data-Rich Spatial Profiling of Cancer Tissue: Astronomy Informs Pathology

Alexander S. Szalay, Janis M. Taube

Clin Cancer Res OF1–OF8.

DOI: https://doi.org/10.1158/1078-0432.CCR-19-3748

Published: 23 May 2022

View article

Journal Articles

Emerging roles of the copper-CTR1 axis in tumorigenesis

Yaqing Su, Xiaomei Zhang, Shaoqiang Li, Wei Xie, Jianping Guo

Mol Cancer Res molcanres.0056.2022-1-17 21:06:19.613.

DOI: https://doi.org/10.1158/1541-7786.MCR-22-0056

Published: 23 May 2022

View article

Journal Articles

Cancer Immunoediting in the Era of Immuno-oncology

Matthew M. Gubin, Matthew D. Vesely

Clin Cancer Res clincanres.1804.2022.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-1804

Published: 20 May 2022

View article

Journal Articles

Drug-tolerant persister cells in cancer therapy resistance

Pavan Kumar. Dhanyamraju, Todd D. Schell, Shantu Amin, Gavin P. Robertson

Cancer Res canres.3844.2021.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3844

Published: 18 May 2022

View article

Journal Articles

RNA in cancer immunotherapy: unlocking the potential of the immune system

Wout de. Mey, Arthur Esprit, Kris Thielemans, Karine Breckpot, Lorenzo Franceschini

Clin Cancer Res clincanres.3304.2022.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-3304

Published: 18 May 2022

View article

Journal Articles

Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine Carcinoma

Melissa Frizziero, Elaine Kilgour, Kathryn L. Simpson, Dominic G. Rothwell, David A. Moore, Kristopher K. Frese, Melanie Galvin, Angela Lamarca, Richard A. Hubner, Juan W. Valle, Mairéad G. McNamara, Caroline Dive

Clin Cancer Res (2022) 28 (10): 1999–2019.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-3058

Published: 13 May 2022

View article

Journal Articles

Molecular Pathways and Mechanisms of BRAF in Cancer Therapy

Poulikos I. Poulikakos, Ryan J. Sullivan, Rona Yaeger

Clin Cancer Res OF1–OF11.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-2138

Published: 12 May 2022

View article

Journal Articles

A road map for designing phase I clinical trials of radiotherapy-novel agent combinations

Sarah R. Brown, Samantha Hinsley, Emma Hall, Chris Hurt, Richard D. Baird, Martin Forster, Andrew F. Scarsbrook, Richard A. Adams

Clin Cancer Res clincanres.4087.2021.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-4087

Published: 12 May 2022

View article

Journal Articles

Optimised systematic review tool: Application to candidate biomarkers for the diagnosis of hepatocellular carcinoma

Mei Ran Abellona U, Eric Yi-Liang Shen, Caroline Cartlidge, Alzhraa Alkhatib, Mark R. Thursz, Imam Waked, Asmaa I. Gomaa, Elaine Holmes, Rohini Sharma, Simon D. Taylor-Robinson

Cancer Epidemiol Biomarkers Prev cebp.0687.2021.

DOI: https://doi.org/10.1158/1055-9965.EPI-21-0687

Published: 11 May 2022

View article

Includes: Supplementary data

Journal Articles

Forkhead Box Transcription Factors: Double-Edged Swords in Cancer

Maria Castaneda, Petra den Hollander, Sendurai A. Mani

Cancer Res OF1–OF9.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-3371

Published: 09 May 2022

View article

Journal Articles

Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment

Simone C. Kleinendorst, Egbert Oosterwijk, Johan Bussink, Harm Westdorp, Mark W. Konijnenberg, Sandra Heskamp

Clin Cancer Res OF1–OF6.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-4332

Published: 09 May 2022

View article

Journal Articles

The Need for New Treatments Targeting MPNST: The Potential of Strategies Combining MEK Inhibitors with Antiangiogenic Agents

Teresa González-Muñoz, AeRang Kim, Nancy Ratner, Héctor Peinado

Clin Cancer Res OF1–OF11.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-3760

Published: 06 May 2022

View article

Journal Articles

The impact of morbidity and disability on attendance at organised breast cancer screening programmes: A systematic review and meta-analysis

Lorna McWilliams, Samantha Groves, Sacha J. Howell, David P. French

Cancer Epidemiol Biomarkers Prev cebp.1386.2021.

DOI: https://doi.org/10.1158/1055-9965.EPI-21-1386

Published: 05 May 2022

View article

Includes: Supplementary data

Journal Articles

Myeloid-Derived Suppressor Cells and Radiotherapy

Carlos Jiménez-Cortegana, Claudia Galassi, Vanessa Klapp, Dmitry I. Gabrilovich, Lorenzo Galluzzi

Cancer Immunol Res (2022) 10 (5): 545–557.

DOI: https://doi.org/10.1158/2326-6066.CIR-21-1105

Published: 03 May 2022

View article

Journal Articles

B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?

Martin Lauss, Marco Donia, Inge Marie Svane, Göran Jönsson

Clin Cancer Res (2022) 28 (9): 1751–1758.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-1130

Published: 02 May 2022

View article

Journal Articles

Immunotherapy of Neuroblastoma: Facts and Hopes

John Anderson, Robbie G. Majzner, Paul M. Sondel

Clin Cancer Res OF1–OF11.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-1356

Published: 29 April 2022

View article

Journal Articles

Intratumor Heterogeneity and Antitumor Immunity Shape One Another Bidirectionally

Yochai Wolf, Yardena Samuels

Clin Cancer Res OF1–OF8.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-1355

Published: 25 April 2022

View article

Journal Articles

Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies

Sana Raoof, Richard J. Lee, Kunal Jajoo, Joseph D. Mancias, Timothy R. Rebbeck, Steven J. Skates

Cancer Epidemiol Biomarkers Prev OF1–OF7.

DOI: https://doi.org/10.1158/1055-9965.EPI-21-1443

Published: 19 April 2022

View article

Journal Articles

Role of Prostaglandin E₂ in the Progression of Gastrointestinal Cancer

David Jay Wilson, Raymond N. DuBois

Cancer Prev Res (Phila) OF1–OF9.

DOI: https://doi.org/10.1158/1940-6207.CAPR-22-0038

Published: 12 April 2022

View article

2 3 4 5

NARROW

Molecular Pathways and Mechanisms of LAG-3 in Cancer Therapy

Data-Rich Spatial Profiling of Cancer Tissue: Astronomy Informs Pathology

Emerging roles of the copper-CTR1 axis in tumorigenesis

Cancer Immunoediting in the Era of Immuno-oncology

Drug-tolerant persister cells in cancer therapy resistance

RNA in cancer immunotherapy: unlocking the potential of the immune system

Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine Carcinoma

Molecular Pathways and Mechanisms of BRAF in Cancer Therapy

A road map for designing phase I clinical trials of radiotherapy-novel agent combinations

Optimised systematic review tool: Application to candidate biomarkers for the diagnosis of hepatocellular carcinoma

Forkhead Box Transcription Factors: Double-Edged Swords in Cancer

Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment

The Need for New Treatments Targeting MPNST: The Potential of Strategies Combining MEK Inhibitors with Antiangiogenic Agents

The impact of morbidity and disability on attendance at organised breast cancer screening programmes: A systematic review and meta-analysis

Myeloid-Derived Suppressor Cells and Radiotherapy

B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?

Immunotherapy of Neuroblastoma: Facts and Hopes

Intratumor Heterogeneity and Antitumor Immunity Shape One Another Bidirectionally

Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies

Role of Prostaglandin E₂ in the Progression of Gastrointestinal Cancer

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only